Trump’s latest tariffs part of ‘new normal’ for retailers, manufacturers
With country-specific tariffs taking hold for imports from numerous trading partners, many companies are considering price hikes and sourcing strategies…
Researchers Evaluate Infection Control Challenges During an RSV Outbreak in a Cognitively Impaired Population
RSV poses a serious risk to older adults in long-term care, highlighting the need for effective outbreak management and infection…
Generic Drug Research Collaboration Opportunities
The Office of Generic Drugs implements the GDUFA Regulatory Science Research Program by collaborating through grants or contracts.
Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML
CPX-351 shows promise for younger adults with therapy-related AML, offering improved survival post-transplant despite lower initial remission rates.
Beyond Pain Control: Understanding and Managing Opioid-Induced Constipation
Discover effective strategies for managing opioid-induced constipation, including the role of PAMORAs and pharmacist involvement in pain management.
Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse Effects
Pharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk…
Who, When, and How: Navigating Combination Therapies in mCRC
Panelists discuss how managing common toxicities in combination therapies requires specific strategies including dose reductions and growth factor support for…
FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management…
FDA Actions to Remove Unapproved Drugs from the Market by Drug
This page lists FDA Actions to Remove Unapproved Drugs from the Market by Drug
Beyond Survival: SUNLIGHT’s Influence on QoL in mCRC
Panelists discuss how the SUNLIGHT trial’s demonstration that adding bevacizumab to trifluridine/tipiracil improves overall survival and progression-free survival represents the…